Anne Ballinger
St Bartholomew's and The Royal London School of Medicine and Dentistry
2 Newark Street
London E1 2AT
UK
Name/email consistency: high
- Management of growth retardation in the young patient with Crohn's disease. Ballinger, A. Expert. Opin. Pharmacother (2002)
- Orlistat: its current status as an anti-obesity drug. Ballinger, A., Peikin, S.R. Eur. J. Pharmacol. (2002)
- Fundamental mechanisms of growth failure in inflammatory bowel disease. Ballinger, A. Horm. Res. (2002)
- Role of hypothalamic neuropeptide Y and orexigenic peptides in anorexia associated with experimental colitis in the rat. Ballinger, A.B., Williams, G., Corder, R., El-Haj, T., Farthing, M.J. Clin. Sci. (2001)
- Growth failure and intestinal inflammation. Ballinger, A.B., Camacho-Hübner, C., Croft, N.M. QJM (2001)
- COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention. Ballinger, A., Smith, G. Expert. Opin. Pharmacother (2001)
- Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Ballinger, A.B., Azooz, O., El-Haj, T., Poole, S., Farthing, M.J. Gut (2000)
- Orlistat in the treatment of obesity. Ballinger, A. Expert. Opin. Pharmacother (2000)
- Divergency of leptin response in intestinal inflammation. Ballinger, A. Gut (1999)